NCT03975647 · Interventional trial
A Study of Tucatinib vs. Placebo in Combination With Ado-trastuzumab Emtansine (T-DM1) for Patients With Advanced or Metastatic HER2+ Breast Cancer
Overall registry status Active not recruiting
Phase 3
Conditions HER2-positive Breast Cancer
Delaware Valley sites
- Hospital of the University of Pennsylvania, Perelman Center for Advanced Medicine · Philadelphia, PA · Philadelphia County
First posted
Registry updated
Added to the directory